Question 1

Does PointState Capital own AZN stock?

Accepted Answer

No. PointState Capital exited its AZN (AstraZeneca) position in Q3 2022. Its Q2 2022 13F listed 67,349 shares worth $4.5M.

Question 2

How many shares of AZN does PointState Capital own?

Accepted Answer

None since Q3 2022, when PointState Capital exited the position. Its Q2 2022 13F listed 67,349 shares worth $4.5M.

Question 3

What is PointState Capital's AZN position worth?

Accepted Answer

PointState Capital's AZN position was worth $4.5M in its Q2 2022 13F, before the exit in Q3 2022.

Question 4

Is PointState Capital buying or selling AZN?

Accepted Answer

In Q3 2022, PointState Capital exited its entire AZN position.

Question 5

When did PointState Capital first buy AZN?

Accepted Answer

PointState Capital first reported AZN in its Q4 2020 13F and listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2022-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$101.88	0
2022-Q2	New	67,349	-	$4.5M	0.1%	$121.88	44
2021-Q4	Exited	0	-100.0%	$0	0.0%	$105.70	0
2021-Q3	Increased	821,899	+23.0%	$49.4M	0.8%	$108.99	50
2021-Q2	Decreased	668,390	-23.1%	$40M	0.7%	$107.83	0
2021-Q1	Increased	869,213	+543.9%	$43.2M	0.9%	$89.51	66
2020-Q4	New	135,000	-	$6.7M	0.1%	$88.29	45